https://www.selleckchem.com/pr....oducts/fumarate-hydr
5c.6579del, p.V2194fs) with variant allele frequency of 0.5%, an amplification with a copy number of 17.3, and an fusion with variant allele frequency of 45.3%. The site of the fusion was exon 24 of fused to exon 10 of The fusion was in-frame and considered to be protooncogenic. Although the patient refused to continue therapy, we suggest that -targeted therapies be tried in such future cases. The expanded applications of the cfDNA assay may open a new horizon in treatment of patients with advanced gastric cancer. The ex
Like
Comment
Share
